How can we get even better at customizing treatment for our patients and thereby achieve improved outcomes? How do we avoid becoming relegated to mere brokers of psychopharmacologic commodities? A few thoughts in this brief communication.
David J. Scheiderer, MD, MBA, DFAPA
Advertisement
Articles by David J. Scheiderer, MD, MBA, DFAPA
Advertisement
Latest Updated Articles
- PNIPs, SNPs, and Phenotypes
Published: September 12th 2014 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Social Challenge of the Powerful Taking Care of the Poor: Columbus Day, Indigenous People’s Day, and More
2
Asynchronous ADHD Assessment: New Tools for Better Evaluation
3
Women Are Diagnosed With ADHD 5 Years Later Than Men
4
Early Dose Management and Up-Titration of Esketamine: ECNP Poster Data
5
